EP3960013B1 - Procédé de fabrication d'un gant et gant - Google Patents

Procédé de fabrication d'un gant et gant Download PDF

Info

Publication number
EP3960013B1
EP3960013B1 EP20193029.4A EP20193029A EP3960013B1 EP 3960013 B1 EP3960013 B1 EP 3960013B1 EP 20193029 A EP20193029 A EP 20193029A EP 3960013 B1 EP3960013 B1 EP 3960013B1
Authority
EP
European Patent Office
Prior art keywords
glove
lining
pathogen inactivating
top layer
inactivating compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP20193029.4A
Other languages
German (de)
English (en)
Other versions
EP3960013C0 (fr
EP3960013A1 (fr
Inventor
Sami LYYTINEN
Tiia LYYTINEN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hofler Oy
Original Assignee
Hofler Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hofler Oy filed Critical Hofler Oy
Priority to EP20193029.4A priority Critical patent/EP3960013B1/fr
Priority to EP21172752.4A priority patent/EP3960014A1/fr
Priority to US18/023,167 priority patent/US20230263249A1/en
Priority to CA3190911A priority patent/CA3190911A1/fr
Priority to PCT/FI2021/050564 priority patent/WO2022043606A1/fr
Priority to AU2021330354A priority patent/AU2021330354A1/en
Publication of EP3960013A1 publication Critical patent/EP3960013A1/fr
Application granted granted Critical
Publication of EP3960013C0 publication Critical patent/EP3960013C0/fr
Publication of EP3960013B1 publication Critical patent/EP3960013B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A41—WEARING APPAREL
    • A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
    • A41D19/00—Gloves
    • A41D19/0006—Gloves made of several layers of material
    • A—HUMAN NECESSITIES
    • A41—WEARING APPAREL
    • A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
    • A41D19/00—Gloves
    • A41D19/001—Linings
    • A—HUMAN NECESSITIES
    • A41—WEARING APPAREL
    • A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
    • A41D19/00—Gloves
    • A41D19/015—Protective gloves
    • A—HUMAN NECESSITIES
    • A41—WEARING APPAREL
    • A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
    • A41D2500/00—Materials for garments
    • A41D2500/10—Knitted
    • A—HUMAN NECESSITIES
    • A41—WEARING APPAREL
    • A41D—OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
    • A41D2500/00—Materials for garments
    • A41D2500/20—Woven

Definitions

  • the invention relates to method of manufacturing a glove and a glove, which glove comprises top layer, an outer surface and an inner surface, which inner surface is configured to be in skin contact when the glove is worn in hand.
  • Pathogens such as bacteria and viruses cause diseases, which may be difficult to cure and require a long time to recover. Some diseases may even fatal.
  • On way to reduce the risk of having a contamination of harmful pathogens is to wear gloves. By wearing gloves skin contacts with possibly contaminated surfaces can be reduced. Gloves are widely used in occupations and workplaces, where there is an increased risk of being infected by harmful pathogens.
  • the gloves used to reduce infection risk are disposable, i.e. they are not intended to be reused after removal.
  • Disposable protective gloves are difficult to put on and take off and their mechanical durability is weak. Gloves are effective in avoiding contamination only, if the hands are disinfected before the gloves are put on. Therefore, gloves lose their protective effect easily in everyday use, where occasional removing the gloves is necessary. Problems relating to the use of the disposable gloves lower the willingness of the people to use gloves for protection.
  • An object of the invention is to provide a method for manufacturing a glove and a glove, with which drawbacks relating to the prior art can be reduced.
  • the present invention relates to a method of manufacturing a glove, which glove comprises top layer, an outer surface and an inner surface, which inner surface is configured to be in skin contact when the glove is worn in hand.
  • Said method comprises a step of providing the inner surface with pathogen inactivating compounds whereby the inner surface is treated with a substance containing pathogen inactivating compounds, said substance comprising solvent and coniferous resin acids in the range of 0,01 to 30 weight-% of the substance.
  • the method comprises a step of manufacturing a lining, said lining having an inner surface and attaching the lining inside the top layer, whereby the inner surface of the lining forms the inner surface of the glove.
  • liquid containing pathogen inactivating compounds is sprayed on the inner surface and the sprayed liquid is allowed to dry to a coating at least partly covering the inner surface.
  • the glove is soaked in a liquid containing pathogen inactivating compounds to impregnate the glove with pathogen inactivating compounds and the soaked glove is allowed to dry.
  • the lining is soaked in a liquid containing pathogen inactivating compounds to impregnate the lining with pathogen inactivating compounds and the soaked lining is allowed to dry.
  • the lining is soaked in a liquid containing pathogen inactivating compounds before the lining is attached inside the top layer.
  • the lining is manufactured of fabrics or of threads which fabrics or threads are treated with a substance containing pathogen inactivating compounds before the lining is manufactured.
  • the top layer is treated with a substance containing pathogen inactivating compounds before the lining is attached inside the top layer.
  • a glove according to the invention comprises a top layer, an outer surface and an inner surface, which inner surface is configured to be in skin contact when the glove is worn in hand.
  • Said inner surface contains pathogen inactivating compounds, wherein said pathogen inactivating compounds comprise coniferous resin acids.
  • the glove comprises a lining inside the top layer, said lining having an inner surface, whereby the inner surface of the lining forms the inner surface of the glove.
  • the inner surface has a coating comprising pathogen inactivating compounds.
  • the top layer and/or the lining is impregnated with pathogen inactivating compounds.
  • the top layer is made of leather or textile and the outer surface of the glove has a coating comprising pathogen inactivating compounds.
  • An advantage of the invention is, that it reduces the risk on being infected by pathogens in everyday situations.
  • Another advantage of the invention is, that the reduces the need and use of disposable gloves, which saves material and environment.
  • a further advantage of the invention is, that it reduces the need of using disinfectants.
  • FIG 1a an embodiment of the glove according to the invention is shown oblique from above.
  • fig. 1b a cross-section the glove of fig. 1a along line A-A is depicted. In the following both figures are explained simultaneously.
  • the glove is a known handheld garment comprising a top layer 10, which has a shape of a hand.
  • the top layer can be made by knitting or by sewing cutted pieces of fabrics or leather together to a desired shape. Further, it is possible to make the top layer from castable material, such as natural or synthetic rubber or plastic by using a mould having a shape of a hand.
  • the top layer 10 has an outer surface 12 and an inner surface 14 ( fig. 1b ).
  • the inner surface is defined to be the surface, which is configured to be in skin contact, when the glove is worn in hand.
  • the outer surface is the surface of the top layer, which remains visible, when a hand is inserted inside the glove.
  • the inner surface 14 is treated with a substance containing pathogen inactivating compounds.
  • pathogen inactivating compounds adhere to inner surface forming a pathogen inactivating coating covering substantially the whole area of the inner surface.
  • Pathogens may include bacteria, viruses and/or fungus. Inactivating here means making the pathogens harmless either by killing them or by significantly reducing their ability to reproduce on animate or inanimate surface and/or infect a human being.
  • the treatment can be made by immersing the substantially finished glove into a liquid containing pathogen inactivating compounds. The soaked glove is then lifted out of the liquid and allowed to dry completely. When the glove dries the molecules of the pathogen inactivating compounds form a dense network on the inner surface and on the outer surface of the clove. If the top layer is knitted or woven fabric or textile or other fibrous material, which is water permeable, the compounds form a covering around the fibres of the top layer. Thus, the whole top layer material becomes impregnated with pathogen inactivating compounds.
  • top layer is made of substantially waterproof material, such as leather, natural or synthetic rubber, plastic, water repellent or waterproof fabric or PU-coated textile, a coating in a form of thin molecular net containing pathogen inactivating compounds is formed and adhered to the inner and outer surfaces of the glove.
  • substantially waterproof material such as leather, natural or synthetic rubber, plastic, water repellent or waterproof fabric or PU-coated textile
  • the treatment with a substance containing pathogen inactivating compounds is made by spraying liquid containing pathogen inactivating compounds on the inner surface 14 of the glove and allowing the sprayed liquid to dry to a coating on the inner surface.
  • a single spray treatment comprises a number of consecutive sprayings and a drying period between each spraying.
  • the number of sprayings in a single spray treatment may be 10 to 20, preferably 15.
  • the drying period between each spraying may be 5 to 10 minutes.
  • the top layer of the glove can be turned inside up for the duration of the spray treatment.
  • a similar spray treatment can be made for the outer surface of the glove also.
  • FIG 2a a second embodiment of the glove according to the invention is seen oblique from above.
  • fig. 2b a cross-section the glove of fig. 2a along line B-B is depicted. In the following both figures are explained simultaneously.
  • the embodiment of the glove depicted in figs. 2a and 2b differs from the embodiment of figs. 1a and 1b in that it further comprises a lining 18 inside the top layer 10.
  • the lining and the top layer have a substantially similar shape, but the lining is slightly smaller, which makes possible to insert the lining inside the top layer.
  • the inner surface of the glove which is defined to be the surface, which is configured to be in skin contact, when the glove is worn in hand, is now the inner surface 14a of the lining 18.
  • the lining is usually made of soft knitted or woven fabric or textile.
  • the lining is attached to the top layer 10 by joint knitting 16 locating in the edge of the wrist surrounding area of the glove.
  • the treatment for a glove shown in figs 2a and 2b with a substance containing pathogen inactivating compounds can be made in a similar way as to the gloves shown in figs. 1a and 1b , i.e. by immersing the substantially finished glove into a liquid containing pathogen inactivating compounds and allowing glove to dry completely.
  • the water permeable lining material becomes impregnated with pathogen inactivating compounds and on the inner surface 14a of the lining a coating containing pathogen inactivating compounds is formed.
  • the top layer becomes impregnated in a similar manner.
  • top layer is made of substantially waterproof material, such as leather, natural or synthetic rubber, plastic, water repellent or waterproof fabric or PU-coated textile, a thin coating containing pathogen inactivating compounds is formed and adhered to the inner and outer surfaces of the top layer.
  • This soaking treatment is a possible treatment method for cloves, if the material of the outer surface of the glove can withstand soaking and wetting without harmful side-effects, such as colour chances.
  • the treatment of the lining 18 and the treatment of the top layer 10 are made in separate phases.
  • the treatment of the lining 18 can be made either by immersing the substantially finished lining into a liquid containing pathogen inactivating compounds and allowing the lining to dry completely or by spraying liquid containing pathogen inactivating compounds at least on the inner surface 14a of the lining and allowing the sprayed liquid to dry as explained above.
  • the lining can be detached from the top layer whereby it is attached to the top layer with a joint knitting 16 after the treatment of the lining is finished. It is also possible to attach the lining to the top layer before treatment and pull the lining out the top layer in a way that only a short strip of lining next to joint knitting remains inside the top layer.
  • the treatment with a substance containing pathogen inactivating compounds is performed. After the treatment is finished and the lining 18 is dry, the lining is pushed back inside the top layer. Further, it possible to treat the manufacturing materials of the lining, i.e. the yarns and fabrics, already before the manufacturing of the lining is started.
  • the substance containing pathogen inactivating compounds used in the method contains natural, biodegradable compounds, which are harmless for the human and for the environment.
  • the substance comprises solvent and coniferous resin acids in the range of 0,01 to 30 weight-% of the substance.
  • the substance comprises primary solvent, coniferous resin acids in the range of 0,01 to 30 weight %, water and an auxiliary solvent selected from E and P series glycol ethers.
  • the amount of primary solvent is preferably in the range from 50 to 95 weight -% and the amount of auxiliary solvent is preferably in the range from 0,001 weight-% to 5 weight -% of the substance.
  • Aforementioned substance has an inactivating effect to numerous bacteria and viruses including SARS, MERS, influenza virus, H1N1 and human coronavirus.
  • the substance has also proven to have adequate adhesion properties, i.e. it sticks and stays in on the inner and outer surface of the glove for an expected lifetime of the glove.
  • the used substance does not include heavy metals, borax, terbinafines, parabens or quaternary ammonium compounds.
  • the inner surface of the glove according to the invention contains aforementioned pathogen inactivating compounds.
  • the glove When the glove is used, i.e. when a hand is inserted inside the glove, the hand is in skin contact with the inner surface and the compounds therein. If the hand carries pathogens, such as bacteria or viruses, the compounds in the inners surface will soon inactivate them. Thus, a hand is disinfected each time the hand is inserter and kept inside a glove for a sufficient time.
  • the glove according to the invention may be a workglove or a leisure time glove. These kinds of gloves are usually kept in hand quite long periods, whereby the pathogen inactivating compounds easily have sufficient time to influence to the pathogens.

Claims (13)

  1. Procédé de fabrication d'un gant, lequel gant comprend une couche supérieure (10), une surface extérieure (12) et une surface intérieure (14), laquelle surface intérieure est configurée pour être en contact avec la peau lorsque le gant est porté sur la main et lequel procédé comprend une étape de fourniture à la surface intérieure (14) de composés inactivant les agents pathogènes, caractérisé en ce que la surface intérieure (14, 14a) est traitée avec une substance contenant des composés inactivant les agents pathogènes, ladite substance comprenant un solvant et des acides résineux de conifères dans la plage de 0,01 à 30 % en poids de la substance.
  2. Procédé selon la revendication 1, dans lequel le procédé comprend une étape de fabrication d'une doublure (18), ladite doublure (18) ayant une surface intérieure (14a) et de fixation de la doublure (18) à l'intérieur de la couche supérieure (10), moyennant quoi la surface intérieure (14a) de la doublure (18) forme la surface intérieure (14) du gant.
  3. Procédé selon la revendication 1 ou 2, dans lequel un liquide contenant des composés d'inactivation de pathogènes est pulvérisé sur la surface intérieure (14, 14a) et le liquide pulvérisé est laissé sécher en un revêtement recouvrant au moins partiellement la surface intérieure (14, 14a).
  4. Procédé selon la revendication 1 ou 2, dans lequel le gant est trempé dans un liquide contenant des composés inactivant les agents pathogènes pour imprégner le gant avec des composés inactivant les agents pathogènes et le gant imbibé est laissé sécher.
  5. Procédé selon la revendication 2, dans lequel la doublure (18) est trempée dans un liquide contenant des composés inactivant les agents pathogènes pour imprégner la doublure (18) avec des composés inactivant les agents pathogènes et la doublure (18) imbibée est laissée sécher.
  6. Procédé selon la revendication 5, dans lequel la doublure (18) est trempée dans un liquide contenant des composés inactivant les agents pathogènes avant que la doublure (18) ne soit fixée à l'intérieur de la couche supérieure (10).
  7. Procédé selon la revendication 2, dans lequel la doublure (18) est fabriquée à partir de tissus ou de fils, lesquels tissus ou fils sont traités avec une substance contenant des composés inactivant les agents pathogènes avant que la doublure (18) ne soit fabriquée.
  8. Procédé selon l'une quelconque des revendications 2 à 7, dans lequel la couche supérieure (10) est traitée avec une substance contenant des composés inactivant les agents pathogènes avant que la doublure (18) ne soit fixée à l'intérieur de la couche supérieure (10).
  9. Gant comprenant une couche supérieure (10), une surface extérieure (12) et une surface intérieure (14), laquelle surface intérieure (14) est configurée pour être en contact avec la peau lorsque le gant est porté sur la main et laquelle surface intérieure (14) contient des composés inactivant les agents pathogènes, caractérisé en ce que lesdits composés inactivant les agents pathogènes comprennent des acides résineux de conifères.
  10. Gant selon la revendication 9, comprenant une doublure (18) à l'intérieur de la couche supérieure (10), ladite doublure (18) ayant une surface intérieure (14a), moyennant quoi la surface intérieure (14a) de la doublure (18) forme la surface intérieure (14) du gant.
  11. Gant selon la revendication 9 ou 10, dans lequel la surface intérieure (14, 14a) a un revêtement comprenant des composés inactivant les agents pathogènes.
  12. Gant selon les revendications 10 ou 11, dans lequel la couche supérieure (10) et/ou la doublure (18) est imprégnée de composés inactivant les agents pathogènes.
  13. Gant selon l'une quelconque des revendications 9 à 12, dans lequel la couche supérieure (10) est faite de cuir ou textile et la surface extérieure (12) du gant a un revêtement comprenant des composés inactivant les agents pathogènes.
EP20193029.4A 2020-08-27 2020-08-27 Procédé de fabrication d'un gant et gant Active EP3960013B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP20193029.4A EP3960013B1 (fr) 2020-08-27 2020-08-27 Procédé de fabrication d'un gant et gant
EP21172752.4A EP3960014A1 (fr) 2020-08-27 2021-05-07 Procédé de fabrication d'un gant et gant
CA3190911A CA3190911A1 (fr) 2020-08-27 2021-08-20 Procede de fabrication d'un gant et gant
PCT/FI2021/050564 WO2022043606A1 (fr) 2020-08-27 2021-08-20 Procédé de fabrication d'un gant et gant
US18/023,167 US20230263249A1 (en) 2020-08-27 2021-08-20 Method of manufacturing a glove and a glove
AU2021330354A AU2021330354A1 (en) 2020-08-27 2021-08-20 Method of manufacturing a glove and a glove

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20193029.4A EP3960013B1 (fr) 2020-08-27 2020-08-27 Procédé de fabrication d'un gant et gant

Publications (3)

Publication Number Publication Date
EP3960013A1 EP3960013A1 (fr) 2022-03-02
EP3960013C0 EP3960013C0 (fr) 2023-06-07
EP3960013B1 true EP3960013B1 (fr) 2023-06-07

Family

ID=72266175

Family Applications (2)

Application Number Title Priority Date Filing Date
EP20193029.4A Active EP3960013B1 (fr) 2020-08-27 2020-08-27 Procédé de fabrication d'un gant et gant
EP21172752.4A Pending EP3960014A1 (fr) 2020-08-27 2021-05-07 Procédé de fabrication d'un gant et gant

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP21172752.4A Pending EP3960014A1 (fr) 2020-08-27 2021-05-07 Procédé de fabrication d'un gant et gant

Country Status (5)

Country Link
US (1) US20230263249A1 (fr)
EP (2) EP3960013B1 (fr)
AU (1) AU2021330354A1 (fr)
CA (1) CA3190911A1 (fr)
WO (1) WO2022043606A1 (fr)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050112180A1 (en) * 2003-11-22 2005-05-26 Chou Belle L. Antimicrobial elastomeric flexible article and manufacturing method
US8499363B2 (en) * 2006-07-28 2013-08-06 Shen Wei (Usa) Inc. Elastomeric flexible article with absorbent polymer and manufacturing method
KR101111158B1 (ko) * 2009-01-16 2012-02-16 김영배 방한용 가죽장갑
EP3340819A4 (fr) * 2015-08-25 2019-03-06 Ansell Limited Gants présentant des renforts et des éléments d'impact

Also Published As

Publication number Publication date
EP3960014A1 (fr) 2022-03-02
EP3960013C0 (fr) 2023-06-07
WO2022043606A1 (fr) 2022-03-03
EP3960013A1 (fr) 2022-03-02
AU2021330354A1 (en) 2023-04-13
US20230263249A1 (en) 2023-08-24
CA3190911A1 (fr) 2022-03-03

Similar Documents

Publication Publication Date Title
CN103874433B (zh) 服装
US20130022659A1 (en) Band, bracelet or strip carrier for an anti-microbial agent to reduce the spread of disease
DE102011055154A1 (de) Schnittfestes oder schnittresistentes Fussbekleidungsstück sowie Verwendung von schnittfesten oder schnittresistenten Garnen für Fussbekleidungsstücke
US9427035B2 (en) Tattoo-revealing garment
EP3960013B1 (fr) Procédé de fabrication d'un gant et gant
EP1256331A3 (fr) Article absorbant les fluides corporels
KR101409235B1 (ko) 골절환자용 깁스
US20040083530A1 (en) Finger and palm protector for public use
KR20180008030A (ko) 발수 장갑 제조방법 및 이에 의해 제조된 발수 장갑
KR20110027191A (ko) 내외피를 가지는 장갑과 그의 제조방법
EP3977883B1 (fr) Procédé de fabrication d'un gant et gant
JPH0343210Y2 (fr)
US20220226163A1 (en) Compression garment
US20040221354A1 (en) Armpit Perspiration Absorber
JP3181349U (ja) 害虫忌避効果を備えた編成手袋
JP3158963U (ja) 抗ウイルス性防護服
JP2786650B2 (ja) 絆創膏
KR200273767Y1 (ko) 깁스용 피부보호대
KR200171402Y1 (ko) 무좀, 습진방지용 밴드
JP3155825U (ja) 抗ウイルス性防護服
CN111093411B (zh) 湿度指示服装
KR20210120357A (ko) 살균 장갑
KR100484964B1 (ko) 세라믹물질의 심지 및 그의 제조방법
KR20160004782A (ko) 바이러스성 급성전염병 전파방지용 피복의 항균 코팅막을 갖는 외피 소재 제조방법
KR200244161Y1 (ko) 죽염 건포제

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20210430

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20220513

GRAJ Information related to disapproval of communication of intention to grant by the applicant or resumption of examination proceedings by the epo deleted

Free format text: ORIGINAL CODE: EPIDOSDIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTC Intention to grant announced (deleted)
INTG Intention to grant announced

Effective date: 20221007

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

Ref country code: AT

Ref legal event code: REF

Ref document number: 1572057

Country of ref document: AT

Kind code of ref document: T

Effective date: 20230615

Ref country code: DE

Ref legal event code: R096

Ref document number: 602020011671

Country of ref document: DE

U01 Request for unitary effect filed

Effective date: 20230622

U07 Unitary effect registered

Designated state(s): AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT SE SI

Effective date: 20230628

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG9D

U20 Renewal fee paid [unitary effect]

Year of fee payment: 4

Effective date: 20230915

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230907

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230908

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231007

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20231007

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602020011671

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20230607

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20230831